Pfizer considers suing Metsera, Novo over topping bid
Digest more
Pfizer said on Friday it has received an early clearance from the U.S. Federal Trade Commission for its proposed acquisition of Metsera , removing a key regulatory hurdle for the deal valued at up to $7.
Metsera, Inc. is at the center of a bidding war between Novo Nordisk and Pfizer, driving its stock up 20%. Learn more about MTSR stock here.
Stocks traded mostly to the downside Thursday with shares of companies in the tech sector leading declines as Meta Platforms and Microsoft fell following the release of their quarterly earnings.These stocks were moving Thursday:Meta Platforms missed analysts’ third-quarter earnings expectations and the stock declined 10%.
The restaurant chain posted a drop in net income and quarterly revenue missed forecasts. Chipotle said economic strains were [turning customers away from its stores](